Angiotensin II Trifluoroacetic Acid Salt (Human)

N-[1-[N-[N-[N-[N-(N2-L-α-Aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-isoleucyl]-L-histidyl]-L-prolyl]-L-phenylalanine; [Ile5]-Ang II; [Ile5]-Angiotensin II; 5-L-Isoleucineangiotensin II; 10: PN: US20130023475 SEQID: 17 unclaimed protein; 10: PN: WO0212471 SEQID: 17 unclaimed sequence; 113: PN: WO2008104000 TABLE: 4 unclaimed sequence; 11: PN: US20030119021 SEQID: 10 unclaimed sequence; 1272: PN: US20050069911 SEQID: 1272 unclaimed sequence; 12: PN: US20090088553 SEQID: 86 unclaimed protein; 12: PN: WO0239997 SEQID: 17 unclaimed sequence; 134: PN: WO02098448 SEQID: 144 unclaimed sequence; 134: PN: WO02098906 SEQID: 144 unclaimed sequence; 13: PN: US20120071544 SEQID: 7 unclaimed sequence; 14: PN: WO2004007538 SEQID: 13 claimed sequence; 14: PN: WO2011020056 SEQID: 95 claimed protein; 154: PN: WO2009126292 TABLE: 4 unclaimed sequence; 17: PN: US6610497 SEQID: 17 unclaimed sequence; 17: PN: US6884771 SEQID: 17 unclaimed sequence; 31: PN: WO0198325 SEQID: 32 claimed protein; 32: PN: US20060014212 SEQID: 32 unclaimed sequence; 32: PN: WO0056345 SEQID: 32 claimed sequence; 7: PN: JP2005291836 SEQID: 6 unclaimed protein; 7: PN: US20040209344 SEQID: 2 unclaimed sequence; 7: PN: WO03072059 SEQID: 8 unclaimed sequence; 80: PN: US6017693 TABLE: 4 claimed sequence; 83: PN: US20050009742 PAGE: 21 claimed sequence; 85: PN: US20080213898 SEQID: 83 claimed sequence; 873: PN: US20040180380 SEQID: 1272 unclaimed sequence; 8: PN: WO2008138350 SEQID: 8 claimed sequence; 8: PN: WO9958140 SEQID: 1 claimed protein; 96: PN: WO2008058016 SEQID: 96 claimed protein; 9: PN: WO2008005531 SEQID: 17 unclaimed sequence; 9: PN: WO2008106043 TABLE: 6 claimed protein; Angiotensin 2; Angiotensin II; Angiotensin II (human); Angiotensin II (mouse); Angiotensin II [Ile5]; Asp-Arg-Val-Tyr-Ile-His-Pro-Phe; Asp1-Ile5-angiotensin II; Human angiotensin II; Ileu5-angiotensin II; Isoleucyl5-angiotensin II

O=C(O)[C@H](CC1=CC=CC=C1)NC([C@H]2N(C([C@H](CC3=CNC=N3)NC([C@H]([C@@H](C)CC)NC([C@H](CC4=CC=C(C=C4)O)NC([C@H](C(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(O)=O)N)=O)=O)=O)=O)=O)=O)CCC2)=O.OC(C(F)(F)F)=O.[F,Cl,Br,I]

InChI=1S/C50H71N13O12.C2HF3O2/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66;3-2(4,5)1(6)7/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55);(H,6,7)/t28-,33-,34-,35-,36-,37-,38-,40-,41-;/m0./s1

IUPAC name: (2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-4-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-guanidinopropyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid2,2,2-trifluoroacetic acid